Wuxi Biologics (Cayman), Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Wuxi Biologics (Cayman), Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 16.71% vs 7.57% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 45.35% vs 8.42% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23,631.80",
          "val2": "20,248.30",
          "chgp": "16.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9,096.20",
          "val2": "6,770.60",
          "chgp": "34.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "155.20",
          "val2": "170.90",
          "chgp": "-9.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1,133.90",
          "val2": "-99.40",
          "chgp": "1,240.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6,217.80",
          "val2": "4,277.70",
          "chgp": "45.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "305.00%",
          "val2": "245.50%",
          "chgp": "5.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

23,631.80

20,248.30

16.71%

Operating Profit (PBDIT) excl Other Income

9,096.20

6,770.60

34.35%

Interest

155.20

170.90

-9.19%

Exceptional Items

1,133.90

-99.40

1,240.74%

Consolidate Net Profit

6,217.80

4,277.70

45.35%

Operating Profit Margin (Excl OI)

305.00%

245.50%

5.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 16.71% vs 7.57% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 45.35% vs 8.42% in Dec 2024

All Annual Results